This is the new treatment approved in the USA

Age usually takes its toll and presbyopia is one of the main factors responsible for it. Now a few drops can change this.

Approved in the US. The drug regulatory agency in the United States, the FDA (Food and Drug Administration), approved a few weeks ago A new treatment against presound. It is a solution for ophthalmic use, a few eye drops, aceclidin, which applied daily can help reduce the effects of this disorder for about ten hours.

A degenerative disorder. The presbyopy is an ocular disorder associated with aging. Over time, our eyes gradually lose their ability to focus close objects, which hinders some of the tasks of our day to day, such as reading.

The presbyopy It usually begins to demonstrate between the age of 40 and 45, although its progress usually touches the roof when we turn 65. Today there are different tools to fight the presbyce, which include the use of lenses or surgery.

Acechlidin. The treatment is based on aceclidin, a compound that had already been proposed in ocular health In other contexts, such as the treatment of some types of glaucoma. The compound acts by contracting the Iris sphincter musclethe person in charge of contracting the pupil, and does so, according to the developers of the new treatment, with a “minimum” stimulation of the ciliary muscle, another eye muscle, is located outside the Iris.

What the treatment is achieved is a stenopic effect by making the pupil contract below the two millimeters. This effect is the one that works wings cameras Pinhole Or Stenopic, which gives them a wide focal range, even losing sharpness as a consequence of diffraction.

Clinical trials. According to They explain from Lenz Therapeuticsthe company responsible for the new treatment, the approval of the FDA comes after a series of clinical trials, controlled and randomized double -blind studies, the Clarity 1, 2 and 3 trials.

Can we check it? For now the treatment is approved in the United States but not in the European Union. In fact, despite having been approved in the United States, the drug is not yet available in the North American country: the responsible pharmaceutical company has put October as the month of launching the new drug.

In Xataka | Those spots on your eye when you look at a clear background are not bugs: they are shadows and destroy them is worse than ignoring them

Image | Towfiqui Barbhuiya /